BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 20431479)

  • 21. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.
    Ducie J; Dao F; Considine M; Olvera N; Shaw PA; Kurman RJ; Shih IM; Soslow RA; Cope L; Levine DA
    Nat Commun; 2017 Oct; 8(1):990. PubMed ID: 29042553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
    Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
    J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
    Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in serous tubal intraepithelial carcinoma: correlation with high grade serous carcinoma and ovarian carcinogenesis.
    Li HX; Lu ZH; Shen K; Cheng WJ; Malpica A; Zhang J; Wei JJ; Zhang ZH; Liu J
    Int J Clin Exp Pathol; 2014; 7(3):848-57. PubMed ID: 24696706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
    Yoon JY; Chapel DB; Goebel E; Qian X; Mito JK; Horowitz NS; Miron A; Soong TR; Xian W; Crum CP
    J Pathol; 2022 Jul; 257(3):255-261. PubMed ID: 35238033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase.
    Sehdev AS; Kurman RJ; Kuhn E; Shih IeM
    Mod Pathol; 2010 Jun; 23(6):844-55. PubMed ID: 20228782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aneuploidy Landscape in Precursors of Ovarian Cancer.
    Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
    Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
    Morrison JC; Blanco LZ; Vang R; Ronnett BM
    Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
    Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
    Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.
    Yamamoto Y; Ning G; Howitt BE; Mehra K; Wu L; Wang X; Hong Y; Kern F; Wei TS; Zhang T; Nagarajan N; Basuli D; Torti S; Brewer M; Choolani M; McKeon F; Crum CP; Xian W
    J Pathol; 2016 Mar; 238(4):519-530. PubMed ID: 26415052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
    Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
    Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma.
    Kuhn E; Wang TL; Doberstein K; Bahadirli-Talbott A; Ayhan A; Sehdev AS; Drapkin R; Kurman RJ; Shih IeM
    Mod Pathol; 2016 Oct; 29(10):1254-61. PubMed ID: 27443516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
    Howitt BE; Hanamornroongruang S; Lin DI; Conner JE; Schulte S; Horowitz N; Crum CP; Meserve EE
    Am J Surg Pathol; 2015 Mar; 39(3):287-93. PubMed ID: 25581732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
    Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
    Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.
    Kuhn E; Kurman RJ; Sehdev AS; Shih IeM
    Int J Gynecol Pathol; 2012 Sep; 31(5):416-22. PubMed ID: 22833080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell Origins of High-Grade Serous Ovarian Cancer.
    Kim J; Park EY; Kim O; Schilder JM; Coffey DM; Cho CH; Bast RC
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.